Moraga-Espinoza, Daniel F.
Eshaghian, Eli
Shaver, Albert
Smyth, Hugh D. C.
Article History
Received: 4 April 2018
Accepted: 18 June 2018
First Online: 12 July 2018
Compliance with Ethical Standards
:
: The author (HDCS) of this paper consults for and has equity ownership in Respira Therapeutics and Nob Hill Therapeutics on inhaled product development. The terms of this arrangement have been reviewed and approved by the University of Texas at Austin in accordance with its policy on objectivity in research.